Self-assembled targeted nanoparticles based on transferrin-modified eight-arm-polyethylene glycol-dihydroartemisinin conjugate

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Liu, Kefeng ^a   Dai, Lin ^b   Li, Chunxiao ^a   Liu, Jing ^a   Wang, Luying ^a   Lei, Jiandu ^a  

^a BEIJING FORESTRY UNIVERSITY   (China)

^b TIANJIN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ARTEMISININ DERIVATIVE; DIHYDROARTEMISININ; LIGAND; MACROGOL DERIVATIVE; NANOPARTICLE; TRANSFERRIN; TRANSFERRIN RECEPTOR;

A-549 CELL LINE; ANIMAL; CANCER TRANSPLANTATION; CELL SURVIVAL; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG SCREENING; FEMALE; HUMAN; HYDROLYSIS; IC50; LEWIS CARCINOMA; MOUSE; PARTICLE SIZE; PH; SOLUBILITY; TISSUE DISTRIBUTION; TUMOR CELL LINE;

A549 CELLS; ANIMALS; ANTINEOPLASTIC AGENTS; ARTEMISININS; CARCINOMA, LEWIS LUNG; CELL LINE, TUMOR; CELL SURVIVAL; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; HYDROLYSIS; INHIBITORY CONCENTRATION 50; LIGANDS; MICE; NANOPARTICLES; NEOPLASM TRANSPLANTATION; PARTICLE SIZE; POLYETHYLENE GLYCOLS; RECEPTORS, TRANSFERRIN; SOLUBILITY; TISSUE DISTRIBUTION; TRANSFERRIN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84977123647     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep29461     Document Type: Article

References (42)

1. Brannon-Peppas, L., Blanchette, J. O. Nanoparticle and targeted systems for cancer therapy. Advanced drug delivery reviews. 56, 1649-1659 (2004).
2. Klayman, D. L. Qinghaosu (artemisinin): an antimalarial drug from China. Science. 228, 1049-1055 (1985).
3. O'Neill, P. M., Posner, G. H. A medicinal chemistry perspective on artemisinin and related endoperoxides. Journal of medicinal chemistry. 47, 2945-2964 (2004).
4. Dell'Eva, R. et al. Inhibition of angiogenesis in vivo and growth of Kaposi's sarcoma xenograft tumors by the anti-malarial artesunate. Biochemical pharmacology. 68, 2359-2366 (2004).
5. Singh, N. P., Lai, H. C. Artemisinin induces apoptosis in human cancer cells. Anticancer research. 24, 2277-2280 (2004).
6. Efferth, T. Molecular pharmacology and pharmacogenomics of artemisinin and its derivatives in cancer cells. Current drug targets. 7, 407-421 (2006).
7. Lai, H., Sasaki, T., Singh, N. P., Messay, A. Effects of artemisinin-tagged holotransferrin on cancer cells. Life sciences. 76, 1267-1279 (2005).
8. AlKadi, H. O. Antimalarial drug toxicity: a review. Chemotherapy. 53, 385-391 (2007).
9. Chen, H., Sun, B., Pan, S., Jiang, H., Sun, X. Dihydroartemisinin inhibits growth of pancreatic cancer cells in vitro and in vivo. Anti-cancer drugs. 20, 131-140 (2009).
10. Hou, J., Wang, D., Zhang, R., Wang, H. Experimental therapy of hepatoma with artemisinin and its derivatives: in vitro and in vivo activity, chemosensitization, and mechanisms of action. Clinical cancer research. 14, 5519-5530 (2008).
11. Brouwers, J., Brewster, M. E., Augustijns, P. Supersaturating drug delivery systems: The answer to solubilitylimited oral bioavailability Journal of pharmaceutical sciences. 98, 2549-2572 (2009).
12. Kolate, A. et al. PEG-a versatile conjugating ligand for drugs and drug delivery systems. Journal of controlled release. 192, 67-81 (2014).
13. Pasut, G., Veronese, F. Polymer-drug conjugation, recent achievements and general strategies. Progress in polymer science. 32, 933-961 (2007).
14. Acharya, S., Sahoo, S. K. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. Advanced drug delivery reviews. 63, 170-183 (2011).
15. Maeda, H., Bharate, G., Daruwalla, J. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. European journal of pharmaceutics and biopharmaceutics. 71, 409-419 (2009).
16. Knop, K., Hoogenboom, R., Fischer, D., Schubert, U. S. Poly (ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. Angewandte chemie international edition. 49, 6288-6308 (2010).
17. Ashley, G. W., Henise, J., Reid, R., Santi, D. V. Hydrogel drug delivery system with predictable and tunable drug release and degradation rates. Proceedings of the national academy of sciences. 110, 2318-2323 (2013).
18. Greenwald, R. B., Choe, Y. H., McGuire, J., Conover, C. D. Effective drug delivery by PEGylated drug conjugates. Advanced drug delivery reviews. 55, 217-250 (2003).
19. Liu, K.-f. et al. Design, synthesis and in vivo antitumor efficacy of novel eight-arm-polyethylene glycol-pterostilbene prodrugs. RSC advances. 5, 51592-51599 (2015).
20. Ahmad, I., Longenecker, M., Samuel, J., Allen, T. M. Antibody-targeted delivery of doxorubicin entrapped in sterically stabilized liposomes can eradicate lung cancer in mice. Cancer research. 53, 1484-1488 (1993).
21. Kirpotin, D. B. et al. Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. Cancer research. 66, 6732-6740 (2006).
22. Bagalkot, V., Farokhzad, O. C., Langer, R., Jon, S. An Aptamer-Doxorubicin Physical Conjugate as a Novel Targeted DrugDelivery Platform. Angewandte chemie international edition. 45, 8149-8152 (2006).
23. Pangburn, T. O., Petersen, M. A., Waybrant, B., Adil, M. M., Kokkoli, E. Peptide-and aptamer-functionalized nanovectors for targeted delivery of therapeutics. Journal of biomechanical engineering. 131, 074005 (2009).
24. Kato, Y., Sugiyama, Y. Targeted delivery of peptides, proteins, and genes by receptor-mediated endocytosis. Critical Reviews™ in Therapeutic drug carrier systems. 14, (1997).
25. Bies, C., Lehr, C.-M., Woodley, J. F. Lectin-mediated drug targeting: history and applications. Advanced drug delivery reviews. 56, 425-435 (2004).
26. Leamon, C. P., Low, P. S. Folate-mediated targeting: from diagnostics to drug and gene delivery. Drug discovery today. 6, 44-51 (2001).
27. Sudimack, J., Lee, R. J. Targeted drug delivery via the folate receptor. Advanced drug delivery reviews. 41, 147-162 (2000).
28. Duf, C., Al Robaian, M., Somani, S. Transferrin and the transferrin receptor for the targeted delivery of therapeutic agents to the brain and cancer cells. Therapeutic delivery. 4, 629-640 (2013).
29. Huang, R.-Q. et al. Efficient gene delivery targeted to the brain using a transferrin-conjugated polyethyleneglycol-modified polyamidoamine dendrimer. The FASEB journal. 21, 1117-1125 (2007).
30. Qian, Z. M., Li, H., Sun, H., Ho, K. Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacological reviews. 54, 561-587 (2002).
31. Joneli, J. et al. Determination of carbohydrate-deficient transferrin in human serum by capillary zone electrophoresis: Evaluation of assay performance and quality assurance over a 10-year period in the routine arena. Electrophoresis. 34, 1563-1571 (2013).
32. Sawant, R. R. et al. Targeted transferrin-modified polymeric micelles: enhanced efficacy in vitro and in vivo in ovarian carcinoma. Molecular pharmaceutics. 11, 375-381 (2013).
33. Xu, C.-C. et al. Synthesis and in vitro antitumor evaluation of dihydroartemisinin-cinnamic acid ester derivatives. European journal of medicinal chemistry. 107, 192-203 (2016).
34. Nam, J.-P. et al. Evaluation of polyethylene glycol-conjugated novel polymeric anti-tumor drug for cancer therapy. Colloids and surfaces B: biointerfaces. 120, 168-175 (2014).
35. Ku, H.-K. et al. Interpretation of protein quantitation using the Bradford assay: comparison with two calculation models. Analytical biochemistry. 434, 178-180 (2013).
36. Wang, D. et al. Ternary system of dihydroartemisinin with hydroxypropyl-cyclodextrin and lecithin: simultaneous enhancement of drug solubility and stability in aqueous solutions. Journal of pharmaceutical and biomedical analysis. 83, 141-148 (2013).
37. Wang, J., Tian, S., Petros, R. A., Napier, M. E., DeSimone, J. M. The complex role of multivalency in nanoparticles targeting the transferrin receptor for cancer therapies. Journal of the American chemical society. 132, 11306-11313 (2010).
38. Shen, Y. et al. Prodrugs forming high drug loading multifunctional nanocapsules for intracellular cancer drug delivery. Journal of the American Chemical Society. 132, 4259-4265 (2010).
39. Dai, L. et al. Novel multiarm polyethylene glycol-dihydroartemisinin conjugates enhancing therapeutic efficacy in non-small-cell lung cancer. Scientific reports. 4 (2014).
40. Madhaiyan, K., Sridhar, R., Sundarrajan, S., Venugopal, J. R., Ramakrishna, S. Vitamin B 12 loaded polycaprolactone nanofibers: a novel transdermal route for the water soluble energy supplement delivery. International journal of pharmaceutics. 444, 70-76 (2013).
41. Ernsting, M. J., Tang, W.-L., MacCallum, N., Li, S.-D. Synthetic modification of carboxymethylcellulose and use thereof to prepare a nanoparticle forming conjugate of docetaxel for enhanced cytotoxicity against cancer cells. Bioconjugate chemistry. 22, 2474-2486 (2011).
42. Wang, L.-L., Hu, R.-C., Dai, A.-G., Tan, S.-X. Bevacizumab induces A549 cell apoptosis through the mechanism of endoplasmic reticulum stress in vitro. International journal of clinical and experimental pathology. 8, 5291 (2015).